|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Zymeworks
gptkb:Acorda_Therapeutics
|
|
gptkbp:awards
|
Best Places to Work
Top Employer in Biotechnology
Corporate Social Responsibility Award
Diversity and Inclusion Award
Innovation Award in Healthcare
|
|
gptkbp:ceo
|
gptkb:Michel_Vounatsos
|
|
gptkbp:clinical_trial
|
gptkb:DJ
gptkb:psychologist
gptkb:Multiple_Sclerosis
|
|
gptkbp:collaborations
|
gptkb:Duke_University
gptkb:Harvard_University
gptkb:Massachusetts_Institute_of_Technology
gptkb:Stanford_University
gptkb:University_of_California
|
|
gptkbp:employees
|
7,500 (2020)
|
|
gptkbp:founded
|
gptkb:1988
|
|
gptkbp:founder
|
gptkb:M._A._(Marty)_Houghton
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bio Gen Corporation
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:invention
|
Over 1,000 patents filed
|
|
gptkbp:market_cap
|
$38 billion (2020)
|
|
gptkbp:partnership
|
gptkb:Alnylam_Pharmaceuticals
gptkb:Sangamo_Therapeutics
gptkb:Ionis_Pharmaceuticals
|
|
gptkbp:philanthropy
|
STEM education initiatives
Community engagement programs
Health equity initiatives
Disability inclusion programs
Biogen Foundation
|
|
gptkbp:products
|
gptkb:Tecfidera
gptkb:Spinraza
gptkb:Avonex
gptkb:Tysabri
|
|
gptkbp:research
|
gptkb:Alfred_Sandrock
|
|
gptkbp:research_focus
|
Neuroscience
Neurodegenerative diseases
Rare diseases
Multiple Sclerosis treatments
Spinal Muscular Atrophy treatments
|
|
gptkbp:revenue
|
$10.5 billion (2020)
|
|
gptkbp:subsidiary
|
gptkb:Bioverativ
Nightstar Therapeutics
|
|
gptkbp:symbol
|
gptkb:BIIB
|
|
gptkbp:website
|
www.biogen.com
|
|
gptkbp:bfsParent
|
gptkb:Biosyn_Corporation
|
|
gptkbp:bfsLayer
|
7
|